Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
Clinical trial NCT00729118 · COMPLETED
Trial details
- NCT number
- NCT00729118
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-26
- Primary completion
- 2019-12-26
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.